DE60234263D1 - Verbesserung der lernfähigkeit und des gedächtnisses und amnesie-behandlung - Google Patents

Verbesserung der lernfähigkeit und des gedächtnisses und amnesie-behandlung

Info

Publication number
DE60234263D1
DE60234263D1 DE60234263T DE60234263T DE60234263D1 DE 60234263 D1 DE60234263 D1 DE 60234263D1 DE 60234263 T DE60234263 T DE 60234263T DE 60234263 T DE60234263 T DE 60234263T DE 60234263 D1 DE60234263 D1 DE 60234263D1
Authority
DE
Germany
Prior art keywords
sub
memory
independently
amnesia
improving learning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60234263T
Other languages
German (de)
English (en)
Inventor
Wen-Mei Fu
Keng-Chen Liang
Wei-Lin Chien
Sheng-Chu Kuo
Fang-Yuan Lee
Che-Ming Teng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carlsbad Technology Inc
Original Assignee
Carlsbad Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlsbad Technology Inc filed Critical Carlsbad Technology Inc
Application granted granted Critical
Publication of DE60234263D1 publication Critical patent/DE60234263D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60234263T 2001-09-14 2002-09-16 Verbesserung der lernfähigkeit und des gedächtnisses und amnesie-behandlung Expired - Lifetime DE60234263D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32238901P 2001-09-14 2001-09-14
US10/242,826 US7049334B2 (en) 2001-09-14 2002-09-13 Enhancement of learning and memory and treatment of amnesia
PCT/US2002/029294 WO2003024397A2 (en) 2001-09-14 2002-09-16 Enhancement of learning and memory and treatment of amnesia

Publications (1)

Publication Number Publication Date
DE60234263D1 true DE60234263D1 (de) 2009-12-17

Family

ID=26935379

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60234263T Expired - Lifetime DE60234263D1 (de) 2001-09-14 2002-09-16 Verbesserung der lernfähigkeit und des gedächtnisses und amnesie-behandlung

Country Status (10)

Country Link
US (1) US7049334B2 (enExample)
EP (1) EP1425011B1 (enExample)
JP (1) JP2005502722A (enExample)
KR (1) KR100889515B1 (enExample)
AT (1) ATE447405T1 (enExample)
AU (1) AU2002327635B2 (enExample)
CA (1) CA2460005C (enExample)
DE (1) DE60234263D1 (enExample)
NZ (1) NZ532022A (enExample)
WO (1) WO2003024397A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077702A1 (en) * 2001-09-14 2004-04-22 Wen-Mei Fu Treatment of nuerodegenerative diseases
JP4499721B2 (ja) 2003-06-30 2010-07-07 ヒフ バイオ，インク． 化合物、組成物および方法
JP2005089457A (ja) * 2003-09-03 2005-04-07 Yung Shin Pharmaceutical Industry Co Ltd 骨成長を促進するまたは骨吸収を阻害するための薬剤組成物
US6984652B2 (en) 2003-09-05 2006-01-10 Warner-Lambert Company Llc Gyrase inhibitors
AU2007276763B2 (en) * 2006-07-24 2011-03-17 University Of Maryland, Baltimore Heme oxygenase inhibitors and methods of therapeutic use
CA2671524A1 (en) * 2006-12-01 2008-06-12 Loma Linda University Medical Center Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240947A (en) * 1992-11-30 1993-08-31 National Science Council 2,3,4,5-substituted furo[2,3-c]pyrazole derivatives
JP2928079B2 (ja) * 1994-02-14 1999-07-28 永信薬品工業股▲ふん▼有限公司 １−（置換ベンジル）−３−（置換アリール）縮合ピラゾール類、その製造法及びその用途
US7115661B1 (en) * 1999-12-29 2006-10-03 Queen's University At Kingston Methods and compositions for mitigating pain
DE19642255A1 (de) * 1996-10-14 1998-04-16 Bayer Ag Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten
DE19744026A1 (de) * 1997-10-06 1999-04-08 Hoechst Marion Roussel De Gmbh Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
GB9920566D0 (en) * 1999-08-31 1999-11-03 Univ London Screen for axon viability
AU2001234602A1 (en) * 2000-01-26 2001-08-07 Cedars-Sinai Medical Center Method for using potassium channel agonists for delivering medicant to an abnormal brain region and/or a malignant tumor
AR031176A1 (es) * 2000-11-22 2003-09-10 Bayer Ag Nuevos derivados de pirazolpiridina sustituidos con piridina

Also Published As

Publication number Publication date
US20030105149A1 (en) 2003-06-05
EP1425011A4 (en) 2007-09-19
EP1425011B1 (en) 2009-11-04
JP2005502722A (ja) 2005-01-27
CA2460005A1 (en) 2003-03-27
AU2002327635B2 (en) 2007-12-13
NZ532022A (en) 2005-12-23
WO2003024397A3 (en) 2003-11-06
EP1425011A2 (en) 2004-06-09
KR20040049307A (ko) 2004-06-11
CA2460005C (en) 2008-12-02
KR100889515B1 (ko) 2009-03-19
US7049334B2 (en) 2006-05-23
ATE447405T1 (de) 2009-11-15
WO2003024397A2 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
CY1108367T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
MXPA02012034A (es) Derivados de tiofeno utiles como agentes anticancerosos.
NO20054970D0 (no) Arylsubstituerte byrazolforbindelser anvendbare som kinaseinhibitorer
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
BR0109165A (pt) Método de tratamento de pólipos colÈnicos
ATE477256T1 (de) Thienylverbindungen
ATE423122T1 (de) Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri)
DK1432705T3 (da) Antibiotika med dobbeltvirkning
DK1483251T3 (da) C3-cyano-epothilon-derivater
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
ATE362366T1 (de) Verwendung von isothiazolderivaten als ureaseinhibitoren zur behandlung von helicobacter pylori verursachte gastrointestinale krankheiten
NO20033959D0 (no) Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon
ATE447405T1 (de) Verbesserung der lernfähigkeit und des gedächtnisses und amnesie-behandlung
DK1000034T3 (da) Substituerede 6-alkylphenanthridiner
TW200510329A (en) Treatment of neurodegenerative diseases
NO20030500D0 (no) Dihydroporfyrinderivater og deres anvendelse
DK1651596T3 (da) Hidtil ukendte derivater af 4,4'-dithiobis-(3-aminobutan-1-sulfonater) og sammensætninger, der omfatter samme
JP2005502722A5 (enExample)
TW200510330A (en) Enhancement of bone growth and inhibition of bone resorption
TW200724137A (en) Cancer treatment
ATE401329T1 (de) Neue antivirale makrocyclische derivate und metallkomplexe, in die verbrückte makrocyclen eingebaut sind
HRP20050126B1 (hr) Fungicidne smjese bazirane na ditianonu
EA200600271A1 (ru) Применение производных индазола для лечения невропатической боли
EA200600614A1 (ru) Фунгицидные смеси для борьбы с патогенами риса

Legal Events

Date Code Title Description
8364 No opposition during term of opposition